Stay updated with breaking news from Captar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AptarGroup, Inc. (NYSE:ATR) Q4 2023 Earnings Call Transcript February 9, 2024 AptarGroup, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen. Thank you for standing by. Welcome to Aptar’s 2023 Fourth Quarter Conference Call. At this time, […]
Voluntis, an Aptar Pharma company and leader in digital therapeutics, today announced a partnership with Tilak Healthcare, a digital therapeutics company specializing in clinically... | February 23, 2022
Join this webinar to discover more about these scientific guidelines and how Aptar Pharma's innovative devices for non-clinical research can meet unmet pharmaceutical needs and... | December 16, 2021
Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced that the company has entered into an exclusive partnership with Aptar Pharma, a global leader